TGA warns on liver toxicity with tocilizumab
The drug has led to jaundice, hepatitis and liver failure, the watchdog says
23rd July 2019
The TGA is investigating the incidence of liver damage associated with the rheumatoid arthritis drug tocilizumab, following adverse events ranging from jaundice to acute hepatic failure.